Metraipolis › archive › dc_3d69ee96e6f2

Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation:… — Europe PMC PMID:41333541

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41333541
DOI
10.1016/j.lanepe.2025.101533
License (as archived)
solo-consultazione
Archived
2026-11-08T12:12:26.705Z
SHA-256 of the archived text
7ebca08e5f99c3275017c9196bc8f8851516c37d7af8a79f99cef9449f2ab41e
Stable URL of this page
https://metraipolis.com/documento/dc_3d69ee96e6f2

How to cite

Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation:… — Europe PMC PMID:41333541 — Europe PMC (en), https://europepmc.org/article/MED/41333541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d69ee96e6f2 (Metraipolis archive dc_3d69ee96e6f2, sha256 7ebca08e5f99c3275017c9196bc8f8851516c37d7af8a79f99cef9449f2ab41e)
BibTeX
@misc{dc3d69ee96e6f2,
  title = {Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation:… — Europe PMC PMID:41333541},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41333541},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d69ee96e6f2; sha256 7ebca08e5f99c3275017c9196bc8f8851516c37d7af8a79f99cef9449f2ab41e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333541. Agents can read the archived copy with the MCP tool read_document.